Swedish Orphan Biovitrum AB
Quotes
Share:
Subscribe:
news.cision.com
/
Swedish Orphan Biovitrum AB
/
Sobi™ to acquire Synagis® US rights from AstraZeneca - creates a platform for global growth
/
Neonatology 028
2 of 2
Neonatology 028
Tue, Nov 13, 2018 08:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Sobi™ to acquire Synagis® US rights from AstraZeneca - creates a platform for global growth
Tue, Nov 13, 2018 08:00 CET
